These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23197158)

  • 21. Identification and characterization of binding sites for human urotensin-II in Sprague-Dawley rat renal medulla using quantitative receptor autoradiography.
    Disa J; Floyd LE; Edwards RM; Douglas SA; Aiyar NV
    Peptides; 2006 Jun; 27(6):1532-7. PubMed ID: 16290260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the UTS2 gene polymorphisms and plasma Urotensin-II levels in breast cancer.
    Yumrutas O; Oztuzcu S; Büyükhatipoglu H; Bozgeyik I; Bozgeyik E; Igci YZ; Bagis H; Cevik MO; Kalender ME; Eslik Z; Arslan A
    Tumour Biol; 2015 Jun; 36(6):4427-32. PubMed ID: 25604143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association analysis of urotensin II gene (UTS2) and flanking regions with biochemical parameters related to insulin resistance.
    Sáez ME; Smani T; Ramírez-Lorca R; Díaz I; Serrano-Ríos M; Ruiz A; Ordoñez A
    PLoS One; 2011 Apr; 6(4):e19327. PubMed ID: 21559414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy.
    Langham RG; Kelly DJ; Gow RM; Zhang Y; Dowling JK; Thomson NM; Gilbert RE
    Am J Kidney Dis; 2004 Nov; 44(5):826-31. PubMed ID: 15492948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model.
    Lescot E; Sopkova-de Oliveira Santos J; Colloc'h N; Rodrigo J; Milazzo-Segalas I; Bureau R; Rault S
    Proteins; 2008 Oct; 73(1):173-84. PubMed ID: 18409194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance.
    Ong KL; Wong LY; Man YB; Leung RY; Song YQ; Lam KS; Cheung BM
    Peptides; 2006 Jul; 27(7):1659-67. PubMed ID: 16597476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ontogeny of the renal urotensin II system in the rat.
    Forty EJ; Ashton N
    Exp Physiol; 2012 Jun; 97(6):785-95. PubMed ID: 22327329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative understanding of UTS2 and UTS2R genes for their involvement in type 2 diabetes mellitus.
    Jiang Z; Michal JJ; Tobey DJ; Wang Z; Macneil MD; Magnuson NS
    Int J Biol Sci; 2008 Apr; 4(2):96-102. PubMed ID: 18463714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A vasoactive peptide: urotensin II].
    Liu GQ; Zeng ZP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):525-8. PubMed ID: 16178453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Significance and Functional Mechanism of UTS2 in Glioblastoma Multiforme.
    Wang Y; Shen L; Sun M
    Curr Cancer Drug Targets; 2024 Jan; ():. PubMed ID: 38265405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function.
    Douglas SA; Dhanak D; Johns DG
    Trends Pharmacol Sci; 2004 Feb; 25(2):76-85. PubMed ID: 15102493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenylpiperidine-benzoxazinones as urotensin-II receptor antagonists: synthesis, SAR, and in vivo assessment.
    Luci DK; Ghosh S; Smith CE; Qi J; Wang Y; Haertlein B; Parry TJ; Li J; Almond HR; Minor LK; Damiano BP; Kinney WA; Maryanoff BE; Lawson EC
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6489-92. PubMed ID: 17933531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urotensin II in the cardiovascular system.
    Richards AM; Charles C
    Peptides; 2004 Oct; 25(10):1795-802. PubMed ID: 15476948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urotensin-II in the lung: a matter for vascular remodelling and pulmonary hypertension?
    Djordjevic T; Görlach A
    Thromb Haemost; 2007 Nov; 98(5):952-62. PubMed ID: 18000598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal effects of human urotensin-II in rats with experimental congestive heart failure.
    Ovcharenko E; Abassi Z; Rubinstein I; Kaballa A; Hoffman A; Winaver J
    Nephrol Dial Transplant; 2006 May; 21(5):1205-11. PubMed ID: 16396970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aminomethylpiperazines as selective urotensin antagonists.
    Hilfiker MA; Zhang D; Dowdell SE; Goodman KB; McAtee JJ; Dodson JW; Viet AQ; Wang GZ; Sehon CA; Behm DJ; Wu Z; Carballo LH; Douglas SA; Neeb MJ
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4470-3. PubMed ID: 18674898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11).
    Marzola E; Camarda V; Batuwangala M; Lambert DG; Calo' G; Guerrini R; Trapella C; Regoli D; Tomatis R; Salvadori S
    Peptides; 2008 May; 29(5):674-9. PubMed ID: 17822806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationships of urotensin II and URP.
    Leprince J; Chatenet D; Dubessy C; Fournier A; Pfeiffer B; Scalbert E; Renard P; Pacaud P; Oulyadi H; Ségalas-Milazzo I; Guilhaudis L; Davoust D; Tonon MC; Vaudry H
    Peptides; 2008 May; 29(5):658-73. PubMed ID: 17931747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.
    Ames RS; Sarau HM; Chambers JK; Willette RN; Aiyar NV; Romanic AM; Louden CS; Foley JJ; Sauermelch CF; Coatney RW; Ao Z; Disa J; Holmes SD; Stadel JM; Martin JD; Liu WS; Glover GI; Wilson S; McNulty DE; Ellis CE; Elshourbagy NA; Shabon U; Trill JJ; Hay DW; Ohlstein EH; Bergsma DJ; Douglas SA
    Nature; 1999 Sep; 401(6750):282-6. PubMed ID: 10499587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic urotensin II receptor antagonist treatment does not alter hypertrophy or fibrosis in a rat model of pressure-overload hypertrophy.
    Kompa AR; Wang BH; Phrommintikul A; Ho PY; Kelly DJ; Behm DJ; Douglas SA; Krum H
    Peptides; 2010 Aug; 31(8):1523-30. PubMed ID: 20452383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.